Fig. 1From: Development of neoplasms in pediatric patients with rheumatic disease exposed to anti-tumor necrosis factor therapies: a single Centre retrospective studyMRI head of a 17-year-old female who developed a basal skull Ewing sarcoma 5.3 years after starting etanercept therapyBack to article page